Panacea Biotec Statistics
Total Valuation
Panacea Biotec has a market cap or net worth of INR 24.18 billion. The enterprise value is 23.25 billion.
Market Cap | 24.18B |
Enterprise Value | 23.25B |
Important Dates
The last earnings date was Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Panacea Biotec has 61.25 million shares outstanding. The number of shares has decreased by -0.66% in one year.
Current Share Class | 61.25M |
Shares Outstanding | 61.25M |
Shares Change (YoY) | -0.66% |
Shares Change (QoQ) | +0.65% |
Owned by Insiders (%) | 68.71% |
Owned by Institutions (%) | 0.09% |
Float | 15.41M |
Valuation Ratios
The trailing PE ratio is 210.36.
PE Ratio | 210.36 |
Forward PE | n/a |
PS Ratio | 3.96 |
PB Ratio | 2.91 |
P/TBV Ratio | 3.05 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 202.57 |
EV / Sales | 3.81 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -12.29 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | -3.47% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 3.15M |
Profits Per Employee | 59,298 |
Employee Count | 1,936 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Panacea Biotec has paid 45.40 million in taxes.
Income Tax | 45.40M |
Effective Tax Rate | 28.99% |
Stock Price Statistics
The stock price has increased by +97.15% in the last 52 weeks. The beta is 0.34, so Panacea Biotec's price volatility has been lower than the market average.
Beta (5Y) | 0.34 |
52-Week Price Change | +97.15% |
50-Day Moving Average | 416.77 |
200-Day Moving Average | 429.28 |
Relative Strength Index (RSI) | 41.99 |
Average Volume (20 Days) | 197,508 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Panacea Biotec had revenue of INR 6.10 billion and earned 114.80 million in profits. Earnings per share was 1.88.
Revenue | 6.10B |
Gross Profit | 3.75B |
Operating Income | -475.70M |
Pretax Income | 156.60M |
Net Income | 114.80M |
EBITDA | -132.35M |
EBIT | -475.70M |
Earnings Per Share (EPS) | 1.88 |
Balance Sheet
The company has 1.10 billion in cash and 222.10 million in debt, giving a net cash position of 879.10 million or 14.35 per share.
Cash & Cash Equivalents | 1.10B |
Total Debt | 222.10M |
Net Cash | 879.10M |
Net Cash Per Share | 14.35 |
Equity (Book Value) | 8.31B |
Book Value Per Share | 136.92 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 61.47%, with operating and profit margins of -7.80% and 1.88%.
Gross Margin | 61.47% |
Operating Margin | -7.80% |
Pretax Margin | 2.57% |
Profit Margin | 1.88% |
EBITDA Margin | -2.17% |
EBIT Margin | -7.80% |
FCF Margin | n/a |
Dividends & Yields
Panacea Biotec does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.66% |
Shareholder Yield | n/a |
Earnings Yield | 0.47% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |